Fulcrum Therapeutics, Inc. (FULC)
10.34
+0.11
(+1.08%)
USD |
NASDAQ |
Feb 10, 16:00
10.34
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Market Cap : 559.58M for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agios Pharmaceuticals, Inc. | 1.583B |
| CorMedix, Inc. | 606.68M |
| ACADIA Pharmaceuticals, Inc. | 3.842B |
| Alnylam Pharmaceuticals, Inc. | 42.64B |
| Savara, Inc. | 1.073B |
Market Cap Related Metrics
| PEG Ratio | -0.0312 |
| Price to Book Value | 2.821 |
| Price | 10.34 |
| Earnings Yield | -11.40% |
| PEGY Ratio | -0.0312 |